Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
Submitted by
admin
on April 1, 2014 - 10:20pm
Source:
Bloomberg
News Tags:
MannKind
inhaled insulin
Afrezza
FDA
diabetes
advisory panels
Headline:
MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
Do Not Allow Advertisers to Use My Personal information
